Xoma | XOMA - Interest Expense On Debt


Xoma reported $3.4M in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Agenus USD 16.02M 2.85M Dec/2025
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Ardelyx USD 5.76M 37K Dec/2025
BioMarin Pharmaceutical USD 2.78M 199K Dec/2025
Curis USD 178K 441K Dec/2023
Eli Lilly USD 114.7M 134.3M Sep/2025
Incyte USD 582K 10K Dec/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Novartis USD 304M 23M Dec/2025
Novartis USD 281M 8M Sep/2025
Pfizer USD 711M 59M Dec/2025
Prothena USD 2.62M 350M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Xoma USD 3.4M 150K Jun/2024